.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Sarcopenia affects nearly 43% of the elderly population in India. Recently, scientists discovered that the translocator protein (TSPO) plays a major role in this condition. Specifically, TSPO and sarcopenia are linked through a mechanism that prevents muscle cells from repairing themselves. This upregulation of TSPO occurs naturally as people age, which leads to a decline in mitochondrial health. However, understanding this pathway provides a roadmap for new treatments. Therefore, researchers are investigating how to reverse muscle loss by inhibiting this specific protein.
Furthermore, the study reveals that high levels of TSPO disrupt the Wnt/β-catenin pathway. Moreover, this disruption stems from the accumulation of reactive oxygen species (ROS). Consequently, muscle precursor cells fail to grow and differentiate. Notably, reducing TSPO levels in aged mice restored mitochondrial integrity and physical strength. In fact, exercise performance improved significantly after treatment. Thus, the TSPO-Wnt/β-catenin axis serves as a bridge between cellular energy and muscle growth.
In addition, targeting TSPO might offer a dual-action approach to treating muscle wasting. Specifically, clinicians could soon use therapies that both boost energy production and restart muscle regeneration. Clinicians in India should monitor mitochondrial health in geriatric patients closely. This research highlights the importance of precision medicine in managing age-related frailty.
TSPO is a protein located in the mitochondria. When it is overexpressed due to aging, it causes oxidative stress and blocks the signaling pathways needed for muscle growth and repair.
Yes, experimental evidence suggests that restoring mitochondrial function by reducing TSPO can significantly improve muscle mass and physical strength in aging models.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Zhang P et al. Mitochondrial Dysfunction in Myoblasts: A TSPO-Dependent Mechanism of Sarcopenia. J Gerontol A Biol Sci Med Sci. 2026 Jun 02. doi: undefined. PMID: 42226012.
Lamba et al. Prevalence and Determinants of Sarcopenia Among Older Adults in India: Insights From the Longitudinal Aging Study in India. J Am Geriatr Soc. 2025. doi: 10.1111/jgs.19373.
Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019 Jun 29;393(10191):2636-2646. doi: 10.1016/S0140-6736(19)31138-9.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study identifies TSPO as a negative regulator of myogenesis in sarcopenia, showing that targeting it can restore muscle mass and mitochondrial health....
3 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
